LncRNA SLNCR phenocopies the E2F1 DNA binding site to promote melanoma progression
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.115608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Kushani Shah und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, …. Hauptthemen laut MEDLINE: E2F1 Transcription Factor, RNA, Long Noncoding, Melanoma, Disease Progression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02141…
- Broad Institute of Harvard and MIT, Cambridge, MA 02141, USA; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
- Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
- Genome Integrity and Structural Biology Laboratory, NIEHS, NIH, Durham, NC 27709, USA.
- Broad Institute of Harvard and MIT, Cambridge, MA 02141, USA; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA; Spatial Technologies Unit, Harvard Medical Scho…
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- Intramural NIH HHS
- National Cancer Institute Division of Cancer Epidemiology and Genetics
- National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases
- National Institute of Environmental Health Sciences
- Swiss National Science Foundation
Zitieren
APA
Shah, K., Anastasakou, E., Sejour, L., Wang, Y., Wert-Lamas, L., Rauchet, C., Studer, S., Goller, S., Distel, R. J., Marasco, W., Perera, L., Vlachos, I. S., & Novina, C. D. (2025). LncRNA SLNCR phenocopies the E2F1 DNA binding site to promote melanoma progression. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115608
Vancouver
Shah K, Anastasakou E, Sejour L, Wang Y, Wert-Lamas L, Rauchet C, et al. LncRNA SLNCR phenocopies the E2F1 DNA binding site to promote melanoma progression. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115608
BibTeX
@article{Shah2025,
author = {Shah, Kushani and Anastasakou, Eleni and Sejour, Leinal and Wang, Yufei and Wert-Lamas, Leon and Rauchet, Christopher and Studer, Sabine and Goller, Simon and Distel, Robert J and Marasco, Wayne and Perera, Lalith and Vlachos, Ioannis S and Novina, Carl D},
title = {LncRNA SLNCR phenocopies the E2F1 DNA binding site to promote melanoma progression},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.115608}
}
EUVIMED